Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* BMI at enrollment \>/= 30~* plan for ASA for preeclampsia prevention~Exclusion Criteria:~* BMI \< 30~* already on ASA

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- 81 mg daily aspirin dose (Type: NO_INTERVENTION): obese women \>30 BMI at risk for preeclampsia will receive recommended 81mg ASA
- 162mg daily aspirin dose (Type: ACTIVE_COMPARATOR): obese women \>30 BMI at risk for preeclampsia will receive increased dose of 162mg ASA

Based on this trial design, predict the completion outcome and termination type (if applicable).